Cargando…
Immunotherapy of Bacillus Calmette-Guérin by targeting macrophages against bladder cancer in a NOD/scid (IL2Rg-/−) mouse model
Bacillus Calmette-Guérin (BCG) is considered to be a successful biotherapy for treating bladder cancer (BCa). However, the underlying mechanisms of BCG have not been completely clarified, to date. The role of macrophages in BCG therapy for BCa has still not been determined in vivo. In the present st...
Autores principales: | Tan, Qing-Long, Zhou, Chang-Yuan, Cheng, Lin, Luo, Min, Liu, Chun-Ping, Xu, Wen-Xing, Zhang, Xian, Zeng, Xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248479/ https://www.ncbi.nlm.nih.gov/pubmed/32319653 http://dx.doi.org/10.3892/mmr.2020.11090 |
Ejemplares similares
-
Predictive biomarkers of response to bacillus Calmette‐Guérin immunotherapy and bacillus Calmette‐Guérin failure for non‐muscle invasive bladder cancer
por: Wang, Ziting, et al.
Publicado: (2022) -
Bacillus Calmette–Guérin Immunotherapy for Cancer
por: Cardillo, Fabíola, et al.
Publicado: (2021) -
Pleural Effusion Caused by Bacillus Calmette-Guérin Immunotherapy for Bladder Cancer
por: Rachakonda, Tara, et al.
Publicado: (2017) -
Comparison of biological features between severely immuno-deficient
NOD/Shi-scid Il2rg(null) and NOD/LtSz-scid
Il2rg(null) mice
por: Nagatani, Mariko, et al.
Publicado: (2019) -
Bacillus Calmette-Guérin in the management of superficial bladder cancer
por: Kapoor, Rakesh, et al.
Publicado: (2008)